Aim & Scope
Journal of Clinical Oncology Reports (ISSN: 2836-5062) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines.
Journal of Clinical Oncology Reports (ISSN: 2836-5062) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines.
Journal of Clinical Oncology Reports (ISSN: 2836-5062) is an Open Access single blinded peer-reviewed medical journal that publishes original research articles, review papers, clinical studies, case reports, editorials, and perspectives etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others.
Journal of Clinical Oncology Reports (ISSN: 2836-5062) deals with the disorders and complications that are cancer-related disorders, tumor progression, oncological complications, therapeutic interventions, and clinical oncology research.
The current research in Journal of Clinical Oncology Reports (ISSN: 2836-5062) involves the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners, and even common people.
Journal of Clinical Oncology Reports (ISSN: 2836-5062) accepts the articles in the fields of: General Clinical Oncology, Medical Oncology, Radiation Oncology, Surgical Oncology, Pediatric Oncology, Geriatric Oncology, Oncology Nursing, Cancer Diagnosis & Staging, TNM Staging System, Cancer Screening, Biomarkers in Oncology, Imaging in Cancer (MRI, CT, PET-CT), Tumor Heterogeneity, Histopathology in Cancer, Genetic Testing in Cancer, Artificial Intelligence in Cancer Diagnosis, Cancer Treatment Modalities, Chemotherapy, Targeted Therapy, Immunotherapy (Checkpoint Inhibitors, CAR-T Therapy), Hormone Therapy, Radiotherapy (External Beam, Brachytherapy, Proton Therapy), Combination Therapy, Hyperthermia Therapy, Bone Marrow Transplantation, Cancer Surgery & Minimally Invasive Techniques, Cancer-Specific Clinical Management, Breast Cancer Management, Lung Cancer Treatment Approaches, Colorectal Cancer Therapy, Prostate Cancer Leukemia, Lymphoma, Myeloma, Brain Tumour, Gynecologic Oncology (Ovarian, Cervical, Endometrial Cancer), Pediatric Cancer (Neuroblastoma, Wilms Tumour), Side Effects & Complications, Chemotherapy-Induced Toxicity, Radiation Side Effects, Tumor Lysis Syndrome, Neutropenia & Infections in Cancer Patients, Oncologic Emergencies (Spinal Cord Compression, Hypercalcemia), Cancer-Associated Thrombosis, Quality of Life in Cancer Patients, Emerging & Advanced Therapies, CRISPR in Oncology, Cancer Vaccines, Tumor-Infiltrating Lymphocytes (TILs), Oncolytic Viruses, Nanotechnology in Cancer Treatment, Personalized Medicine in Cancer
Authors can contribute their valuable submission through online and/or to info@mediresonline.org
General Clinical Oncology: is the medical specialty focused on diagnosing, treating, and managing cancer in patients. It involves using therapies such as chemotherapy, radiotherapy, and targeted treatments. The field also emphasizes patient care, monitoring, and improving quality of life during treatment.
Medical Oncology: is the branch of oncology that specializes in the diagnosis and treatment of cancer using medications, including chemotherapy, immunotherapy, and targeted therapy. It focuses on managing systemic disease and coordinating care with other cancer treatments. Medical oncologists monitor patient response and adjust therapies to improve outcomes.
Radiation Oncology: is the medical specialty that uses high-energy radiation to treat cancer. It targets tumors while minimizing damage to surrounding healthy tissues. Radiation oncologists plan and deliver treatments to control or eliminate cancer and improve patient outcomes.
Surgical Oncology: is the branch of oncology that focuses on the surgical removal of tumors and cancerous tissues. It plays a key role in diagnosing, staging, and treating cancer. Surgical oncologists aim to remove cancer effectively while preserving function and improving patient outcomes.
Pediatric Oncology: is the medical specialty focused on the diagnosis and treatment of cancers in children and adolescents. It deals with unique cancer types, such as leukemia and neuroblastoma. Treatment often involves chemotherapy, surgery, radiotherapy, and supportive care tailored for young patients.
Cancer Screening: is the process of detecting cancer early in asymptomatic individuals using tests like imaging, blood markers, or biopsies. Early detection improves treatment effectiveness and survival rates. Regular screening is recommended for high-risk populations to prevent advanced disease.
Genetic Testing in Cancer: involves analyzing DNA to identify mutations that increase cancer risk or influence treatment response. It helps in early detection, risk assessment, and personalized therapy. Genetic testing guides preventive measures and targeted treatments for better patient outcomes.
Hyperthermia Therapy: is a cancer treatment that uses controlled heat to damage or kill cancer cells. It enhances the effectiveness of radiation and chemotherapy. The therapy targets tumors while minimizing harm to surrounding healthy tissues.
Oncolytic Viruses: are genetically engineered or naturally occurring viruses that selectively infect and kill cancer cells. They stimulate the immune system to attack tumors and can be used alone or with other cancer therapies. This approach is being explored for targeted and personalized cancer treatment.
Nanotechnology in Cancer Treatment: involves using nanoparticles to deliver drugs, genes, or imaging agents directly to cancer cells. It enhances the precision, efficacy, and safety of therapies while minimizing side effects. Nanotechnology also aids in early detection, targeted therapy, and monitoring treatment response.
